Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440047 · ClinicalTrials.gov registry record · NA
Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
A NA study of Gastro-Intestinal Disorder, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 355
- Enrollment target
- 2
- Study locations
NCT03440047: Completed NA study of Gastro-Intestinal Disorder, sponsored by Mayo Clinic.
NCT03440047 is a NA study of Gastro-Intestinal Disorder that has completed, run by Mayo Clinic. The registered enrollment target is 355 participants, above the 147-participant average among 6 other Gastro-Intestinal Disorder trials with a reported enrollment target (141% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03440047, a NA study of Gastro-Intestinal Disorder, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.
Conditions Studied
Interventions
- DEVICE Fuji Flim Processor VP-7000, Light Source BL-7000
Study Locations (2)
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03440047
The ClinicalTrials.gov registry entry for NCT03440047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 355 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 147-participant average among 6 other Gastro-Intestinal Disorder trials with a reported enrollment target (141% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastro-Intestinal Disorder appearing as the primary indexed condition, and to 1 intervention - of which Fuji Flim Processor VP-7000, Light Source BL-7000 is the first listed.
NCT03440047 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03440047 about?
NCT03440047 is a clinical study titled "Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim". The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.
What is the current status of trial NCT03440047?
This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2017-08-28. Estimated completion is 2023-03-01.
What conditions does trial NCT03440047 study?
This clinical trial studies the following conditions: Gastro-Intestinal Disorder.
What interventions are being tested in trial NCT03440047?
The interventions under investigation include: Fuji Flim Processor VP-7000, Light Source BL-7000 (DEVICE).
Who is sponsoring clinical trial NCT03440047?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03440047 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastro-Intestinal Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gastroparesis Registry 4
RECRUITING
-
Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
RECRUITING · Phase 1
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Biological Sample Repository for Gastrointestinal Disorders
ACTIVE NOT RECRUITING
-
The Gut-Brain Study
ACTIVE NOT RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.